These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 5938593)

  • 1. [Comparative evaluation of acute toxicity of 2-ethoxybenzamide and phenacetin].
    Teuchmann JK
    Pol Tyg Lek; 1966 Apr; 21(16):577-8. PubMed ID: 5938593
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and D-mannitol.
    Lina BA; Woutersen RA; Bruijntjes JP; van Benthem J; van den Berg JA; Monbaliu J; Thoolen BJ; Beems RB; van Kreijl CF
    Toxicol Pathol; 2004; 32(2):192-201. PubMed ID: 15200157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenacetin: an overview of its toxicity, metabolism and analysis.
    Fishbein L
    IARC Sci Publ; 1981; (40):287-310. PubMed ID: 7035350
    [No Abstract]   [Full Text] [Related]  

  • 4. [The influences of ergotamine and cyclizine on acute toxicity ana analgesic activity of the combined analgesics].
    Tsutsumi S; Sakai S
    Shikwa Gakuho; 1972 Apr; 72(4):875-80. PubMed ID: 4506152
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental studies on the chronic toxicity of a new analgetic mixture. Comparison with analgetic pills containing phenacetin].
    Teuchmann JK; Korolkiewicz Z
    Pol Tyg Lek; 1966 Feb; 21(6):212-4. PubMed ID: 5907391
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenacetin acts as a weak genotoxic compound preferentially in the kidney of DNA repair deficient Xpa mice.
    Luijten M; Speksnijder EN; van Alphen N; Westerman A; Heisterkamp SH; van Benthem J; van Kreijl CF; Beems RB; van Steeg H
    Mutat Res; 2006 Apr; 596(1-2):143-50. PubMed ID: 16464479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic toxicity of 4-chloroanilide of 5-chlorosalicylic acid (Arylide)].
    Noyszewska-Skibińska I; Homrowska H; Hennig J; Ernest K
    Pneumonol Pol; 1977 Aug; 45(8):529-35. PubMed ID: 896544
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenacetin safety.
    Macklin AW; Welch RM
    Science; 1980 Jan; 207(4427):129-30, 132. PubMed ID: 7350647
    [No Abstract]   [Full Text] [Related]  

  • 9. The acute oral toxicity of phenacetin.
    BOYD EM
    Toxicol Appl Pharmacol; 1959 May; 1(3):240-9. PubMed ID: 13659531
    [No Abstract]   [Full Text] [Related]  

  • 10. Thymosin fraction 5 does not influence urinary tract carcinogenesis by phenacetin and N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice.
    Murai T; Iwata H; Mori S; Hato F; Kimura S; Kinoshita Y; Wada S; Kishimoto T; Makino S; Oohara T
    Oncol Res; 1995; 7(3-4):139-44. PubMed ID: 8555647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenacetin.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():135-61. PubMed ID: 7009389
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nasometric and clinical evaluation of a new influenza tablet].
    WANDERLEY AA; MAGALHAES A; LESZEK G
    Hospital (Rio J); 1963 Jan; 63():85-9. PubMed ID: 13998764
    [No Abstract]   [Full Text] [Related]  

  • 13. [Identification of drugs through their metabolic products such as phenacetin, salicylamides, carbamazepine].
    Goenechea S
    Beitr Gerichtl Med; 1972; 29():389-97. PubMed ID: 5082000
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute poisoning with phenacetin and sedative combination preparations containing phenacetin].
    ENGELHARDT G; ZUCKMAYER B; LENDLE L
    Arzneimittelforschung; 1959 Dec; 9():728-34. PubMed ID: 13820340
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of product inhibition on elimination kinetics of ethoxybenzamide in rabbits. Analysis by physiological pharmacokinetic model.
    Lin JH; Sugiyama Y; Hanano M; Awazu S
    Drug Metab Dispos; 1984; 12(2):253-6. PubMed ID: 6144493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two observations of erythema on the ninth day caused by phenacetin-uria].
    MICHAUX L; SAULNIER M
    Arch Fr Pediatr; 1952; 9(7):738-40. PubMed ID: 12986918
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical aspects of chronic poisoning with phenacetin].
    FEDOTOVA VA; KHORSOVA NI
    Klin Med (Mosk); 1952 Apr; 30(4):88. PubMed ID: 14928456
    [No Abstract]   [Full Text] [Related]  

  • 18. Carcinogenicity of phenacetin.
    Tomatis L
    Science; 1979 Apr; 204(4389):129-30. PubMed ID: 432634
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological study of combination of bitionol with phenasal].
    Gladkikh VF; Lebedeva MN; Sazonova EV
    Med Parazitol (Mosk); 1968; 37(6):675-7. PubMed ID: 5732027
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term phenacetin loading in dogs with reference to liver and kidney pigmentation].
    Studer A; Schärer K
    Schweiz Med Wochenschr; 1965 Jul; 95(28):933-41. PubMed ID: 5836063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.